JPRN-UMIN000029787已完成未知
Efficacy and safety of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure - Tolvaptan in CKD Stage 4-5 with CHF
Department of Nephrology, Nippon Medical School0 个研究点目标入组 50 人开始时间: 2017年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Hemodynamics are unstable 2) Hypersensitivity to tolvaptan 3) Anuria 4) Can not feel dry mouth or can not drink water 5) Hypernatremia 6) Pregnant 7) Already prescribed tolvaptan 8) Patient judged inappropriate by the examining physician
研究者
相似试验
招募中
不适用
Efficacy and safety of tolvaptan in patients with severe aortic stenosis and chronic kidney disease undergoing transcatheter aortic valve replacementJPRN-UMIN000033577Tokyo Women's Medical University40
招募中
1 期
Efficacy and safety of tolvaptan for patients with ascites after liver resection, prospective study(Efficacy and safety of tolvaptan after liver resection, prospective study)JPRN-jRCTs061220114Ohdan Hideki30
招募中
不适用
Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventionalJPRN-UMIN000008712Division of Kidney and Hypertension, the Jikei University School of Medicine40
招募中
不适用
A Study of efficacy of Tolvaptan for Patients with Chronic Heart Failurechronic heart failureJPRN-UMIN000009897Department of Medicine II, Kansai Medical University,20
已完成
不适用
A Trial of the effect of tolvaptan on patients with nephrotic state and chronic heart failureJPRN-UMIN000011763Shonan Kamakura General Hospital20